Contents
Contents
DME kickbacks buy referrals, prescriptions or durable medical equipment business that a supplier then bills to Medicare or another federal health care program. The payment may travel through a marketer, an order broker or a staffing company before reaching the person who signs. A supplier employee may see an invoice for marketing. A clinician may see a fee for reviewing a chart. The useful question is what the money bought and which equipment claims followed it. When a paid order replaces a medical decision, taxpayers fund equipment the patient may not need.
A lead fee buys contact information or a connection to a prospective patient. A per-order fee buys a completed prescription. A clinician’s review fee pays for a different step again.
The industry’s order chain separates advertising, lead capture, clinical authorization, the written order, and supplier fulfillment and billing. A call center may charge per lead or transferred call. A telemedicine staffing company may charge per consultation or chart. The supplier receives the paperwork needed to support its equipment claim. Several businesses can earn money before the item reaches the patient.
In a 2024 Iowa settlement announcement, the Justice Department alleged that a nurse practitioner received $20 per patient reviewed and spent as little as nine seconds reviewing a record.
The Richland physician and staffing-company settlement shows the intermediary’s place. The government alleged that Nationwide Health Advocates used telemarketers to contact beneficiaries, generated orders and supporting records, and routed them to a physician through Jackson & Coker LocumTenens. Nationwide paid the staffing company, which paid the physician per order reviewed. The payment path connected the marketer to the signature even though they had a company between them.
An invoice’s description can conceal the purchase of a signed order. In its March 2026 account of a Texas criminal case, the Justice Department described a supplier owner who had pleaded guilty to a healthcare fraud conspiracy. According to the criminal court documents described in that announcement, he paid kickbacks for signed doctors’ orders and billing paperwork, called the orders leads and called the services marketing. Doctors issued the orders without examining or treating the patients. The supplier used them to claim that the braces were medically necessary.
Calling the transaction marketing made it sound like advertising. The deliverable was the doctor’s order.
Yes. A referral payment can reach a doctor’s office through goods or services as well as cash. The Justice Department’s Respironics settlement announcement explains that the Anti-Kickback Statute prohibits paying money or giving goods to induce referrals for items covered by federal health care programs such as Medicare, Medicaid and TRICARE, and that claims resulting from those violations can create False Claims Act liability.
In that 2023 settlement, the government alleged that Respironics gave sleep laboratories free masks to induce their physicians to prescribe Respironics-brand masks. Suppliers would fill the prescriptions and bill the federal programs. The alleged benefit went to the laboratory, the prescription came from its physician, and the claim came from the supplier.
Calling a payment a consulting fee leaves the central question unanswered: what did the recipient do to earn it?
Value can also take the form of business sent back. In the 2017 Pacific Pulmonary Services settlement, the government alleged that patient care coordinators referred patients to sleep-testing clinics in exchange for those clinics referring patients back for sleep therapy equipment. A former sales representative brought the whistleblower case, and the government joined it. The alleged bargain traded access to patients in both directions.
The supplier’s claim is the destination of the order chain. An advertisement attracts a response. A call center collects contact and insurance information. A staffing company or clinician network supplies the practitioner. The practitioner produces the order, and the supplier ships or fits the item and bills Medicare.
The handoffs leave different records. The advertising and call records show how the beneficiary entered the chain. The contract and invoices show what the supplier agreed to buy. The clinical record and order show what the practitioner reviewed and prescribed. Delivery records and billing data connect that order to the item and the claim.
The HHS Office of Inspector General’s 2022 telemedicine fraud alert describes practitioners receiving compensation framed as payment per review, audit, consultation or chart assessment. It identifies arrangements in which practitioners lack enough contact or information to assess medical necessity, and telemedicine companies sell the resulting orders. The clinical step can become the production step for something another business sells.
A clinician can know how little information accompanied an order without seeing what the supplier later billed. A biller can see repeated claims without seeing how the clinician was paid. You can speak with us about the part you see without having the supplier’s final Medicare claims.
A purchased lead also raises a separate question about how the supplier contacted the beneficiary. The Medicare supplier telephone-contact law generally requires written permission or a qualifying existing relationship. When a supplier knowingly makes a prohibited call, the law bars payment for items the supplier subsequently furnishes to that beneficiary.
The U.S. Healthcare Supply and Oxford Diabetic Supply settlement illustrates the connection. The government alleged that the suppliers set up and controlled Diabetic Experts to make unsolicited calls, then billed for equipment sold through those calls. The allegations followed the suppliers’ control of the calling company all the way to the equipment claims.
AZ Diabetic Supply’s payment arrangements made the difference between a lead and an order explicit. In its complaint, the government alleged that RealTime sold qualified leads to LPI for $150 each in 2017. LPI paid telemedicine doctors to turn them into prescriptions, then sold the prescriptions and beneficiary data to durable medical equipment suppliers.
The complaint described what AZ Diabetic Supply bought:
AZD purchased prescriptions from LPI in exchange for a flat fee of $400 for each DME prescription.
United States v. AZ Diabetic Supply, Inc., government complaint, paragraph 38
In its separate dealings with RealTime, the supplier allegedly paid more for prescriptions for more expensive braces. The government alleged that prescriptions arrived through Dropbox or other cloud services from the middlemen, rather than directly from the patients’ providers. When Medicare denied a purchased prescription because a same or similar item had already been supplied, the broker allegedly supplied a replacement prescription.
A denied claim became a reason to request another piece of merchandise from the broker. That replacement practice showed what the supplier expected its payment to produce.
The complaint attributed $612,329 in Medicare payments to 923 claims resulting from the alleged kickbacks. The Justice Department announced in September 2023 that the court had ordered the company to pay $12,036,554 in False Claims Act damages and penalties.
The government’s complaint alleged that Vision Quest Industries paid a sales intermediary a commission of 20% to 35% on each brace purchased by participating Osteo Relief clinics, without the clinics knowing about the commission.
Medicare sets equipment payment amounts, while orders come from a dispersed population of practitioners. Referral access and order volume therefore matter to suppliers’ revenue. A business that can repeatedly deliver signed orders controls something the supplier needs before it can bill.
The commercial value of patient access predates the telemedicine order market. In testimony published in the House Ways and Means Committee’s 2003 hearing, Waste, Fraud, and Abuse, the Justice Department described Operation Headwaters, a criminal investigation of durable medical equipment manufacturers. The FBI posed as a national distributor with access to more than 6,000 Medicare patients. The investigation covered enteral feeding, diabetic footwear and wound care products. Access to the patients was part of what made the supposed distributor commercially attractive.
Today’s purchased-order cases show that access bundled with another valuable input: the prescription needed for the supplier’s claim.
Payments that rise with completed orders, clinical reviews lasting seconds, prescriptions delivered by brokers, and replacement orders supplied after claim denials are concrete signals in durable medical equipment kickback cases. They connect the commercial arrangement to the paperwork used for billing.
Ownership records can reveal who directs that arrangement. In a 2025 Florida criminal-case announcement, the Justice Department described an owner who had pleaded guilty and secretly controlled five suppliers. According to the criminal court documents described in the announcement, paid nominee owners and falsified enrollment and bank records concealed his control, while a co-conspirator paid patient recruiters for beneficiary referrals. The business named on a payment and the person controlling it could tell different stories.
The useful evidence connects a payment to an order, the supplier’s claim and the people who understood the arrangement. Marketing contracts, lead invoices, payment schedules, order versions, review logs, clinical records, delivery records and claims each answer a different part of that question.
A call-center employee may know how the patient was recruited. A clinician may know whether the chart supported the order. Someone in accounts payable may know whether a vendor received payment for a lead, a signed prescription or an item Medicare reimbursed. A biller may recognize the replacement order after the first claim was denied.
We work through those connections with you. The strongest account explains what the business promised to buy, what it actually received, where the money went and which federal claims followed.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know what a lead invoice, referral deal or review fee bought, speak to one of our Whistleblower Experts about the arrangement. We build your strongest DME kickback whistleblower case with you, bring in durable medical equipment whistleblower lawyers who understand order buying and kickbacks, and stay beside you throughout the process.